Detalhe da pesquisa
1.
Immediate Breast Reconstruction After Neoadjuvant Chemotherapy: Factors Associated With Surgical Selection and Complications.
Ann Plast Surg
; 91(1): 48-54, 2023 07 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37216212
2.
Neoadjuvant pyrotinib, trastuzumab, and docetaxel for HER2-positive breast cancer (PHEDRA): a double-blind, randomized phase 3 trial.
BMC Med
; 20(1): 498, 2022 12 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-36575513
3.
A nomogram for predicting axillary pathologic complete response in hormone receptor-positive breast cancer with cytologically proven axillary lymph node metastases.
Cancer
; 126 Suppl 16: 3819-3829, 2020 08 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-32710664
4.
Current Status and Factors Influencing Surgical Options for Breast Cancer in China: A Nationwide Cross-Sectional Survey of 110 Hospitals.
Oncologist
; 25(10): e1473-e1480, 2020 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-32333626
5.
Tumoral PD-1hiCD8+ T cells are partially exhausted and predict favorable outcome in triple-negative breast cancer.
Clin Sci (Lond)
; 134(7): 711-726, 2020 04 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-32202617
6.
Changing patterns and survival improvements of young breast cancer in China and SEER database, 1999-2017.
Chin J Cancer Res
; 31(4): 653-662, 2019 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-31564808
7.
[Current trends of breast reconstruction after mastectomy for breast cancer patients in China: a survey report].
Zhonghua Zhong Liu Za Zhi
; 36(11): 851-7, 2014 Nov.
Artigo
em Zh
| MEDLINE | ID: mdl-25620484
8.
CRTAM promotes antitumor immune response in triple negative breast cancer by enhancing CD8+ T cell infiltration.
Int Immunopharmacol
; 129: 111625, 2024 Mar 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-38354509
9.
Somatic mutations in a multigene panel and impact on prognosis based on TP53 status in Chinese HER2-positive patients undergoing neoadjuvant therapy: A single-institution retrospective cohort.
Cancer Med
; 13(2): e6955, 2024 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-38379328
10.
Latissimus dorsi flap - the main force in breast reconstruction for breast tumor in Chinese population.
Front Oncol
; 13: 1159073, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-37546409
11.
Clinical feasibility and oncological safety of non-radioactive targeted axillary dissection after neoadjuvant chemotherapy in biopsy-proven node-positive breast cancer: a prospective diagnostic and prognostic study.
Int J Surg
; 109(7): 1863-1870, 2023 Jul 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37132193
12.
Predicting sentinel lymph node metastasis in a Chinese breast cancer population: assessment of an existing nomogram and a new predictive nomogram.
Breast Cancer Res Treat
; 135(3): 839-48, 2012 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-22941537
13.
Diagnostic performance of a novel high-resolution dedicated axillary PET system in the assessment of regional nodal spread of disease in early breast cancer.
Quant Imaging Med Surg
; 12(2): 1109-1120, 2022 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-35111608
14.
The Prognoses of Young Women With Breast Cancer (≤35 years) With Different Surgical Options: A Propensity Score Matching Retrospective Cohort Study.
Front Oncol
; 12: 795023, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-35296009
15.
Benefits of neoadjuvant therapy compared with adjuvant chemotherapy for the survival of patients with HER2-positive breast cancer: A retrospective cohort study at FUSCC.
Breast
; 63: 177-186, 2022 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-35429731
16.
Treatment and survival outcomes in older women with primary breast cancer: A retrospective propensity score-matched analysis.
Breast
; 66: 24-30, 2022 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-36096070
17.
Surgical options of the breast and clinical outcomes of breast cancer patients after neoadjuvant chemotherapy: A single-center retrospective study.
Front Oncol
; 12: 984587, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-36387082
18.
Efficacy and Safety of Mitoxantrone Hydrochloride Injection for Tracing Axillary Sentinel Nodes in Breast Cancer: A Self-Controlled Clinical Trial.
Front Oncol
; 12: 914057, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-35756664
19.
Immunosuppressive lncRNA LINC00624 promotes tumor progression and therapy resistance through ADAR1 stabilization.
J Immunother Cancer
; 10(10)2022 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-36252997
20.
CACA Guidelines for Holistic Integrative Management of Breast Cancer.
Holist Integr Oncol
; 1(1): 7, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-37520336